MedElevator Войти в исследования
← Поиск публикаций

DOI 10.36721/pjps.2026.39.6.176.1

Медицинская библиотека · Pakistan journal of pharmaceutical sciences · 2026

Proteome-based identification and validation of NXPE3 in childhood acute lymphoblastic leukaemia.

Tabassum Najia, Khurshid Yamna, Syed Basir, Ahmed Aftab, Muhammad Sadia, Imad Rehan, Mirza Talat

СтатьяВалидационное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Childhood acute lymphoblastic leukaemia (cALL) tends to metastasize to central nervous system. Treatment with antileukemic agents against CNS leukaemia is an essential component for cure in ALL. Hence, it is essential to identify biomarkers for CNS infiltration. Proteomics, supported by mass spectrometry, is the platform for exploring biomarkers in various biological samples, contributing to translational research.

OBJECTIVES

This study aimed to identify the plasma proteome profile of children across different risk groups of cALL. Neurexophilin and PC-esterase family, member 3 (NXPE3), was validated. The protein-protein interactions (PPI) of NXPE3 were evaluated with bioinformatics analyses.

METHODS

Plasma samples from 15 patients with B-ALL standard risk (SR), B-ALL high risk (HR) and T-ALL high risk (HR), were analysed using LC-MS/MS. NXPE3 protein was validated in all risk groups using ELISA. To compare the NXPE3 values across groups, the Kruskal-Wallis test was applied. A p-value < 0.05 was considered significant. STRING database was used for PPI.

RESULTS

LC MS/MS analysis showed upregulation of NXPE3 in B-ALL SR. Upon ELISA validation, a high plasma concentration of NXPE3 was observed in B-ALL SR, 4.37±1.84 ng/ml (95% CI 3.31, 5.44), consistent with LC MS/MS findings. A lower concentration of NXPE3 was observed in B-ALL HR 2.68±1.34 ng/ml and T-ALL HR 2.38±0.92ng/ml. The findings were statistically significant. The PPI of NXPE3 highlighted its involvement in multiple processes, including gene expression, cytoskeletal organisation and neuronal function.

CONCLUSION

This is the first report of NXPE3 in cALL. NXPE3 was identified as a potential biomarker for assessing CNS infiltration in cALL. Further studies are recommended to explore its role in leukemogenesis.

Для цитирования: Tabassum Najia, Khurshid Yamna, Syed Basir, Ahmed Aftab, Muhammad Sadia, Imad Rehan, Mirza Talat. Proteome-based identification and validation of NXPE3 in childhood acute lymphoblastic leukaemia.. Pakistan journal of pharmaceutical sciences. 2026. DOI: 10.36721/pjps.2026.39.6.176.1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.